U.S. markets closed
  • S&P 500

    4,026.12
    -1.14 (-0.03%)
     
  • Dow 30

    34,347.03
    +152.97 (+0.45%)
     
  • Nasdaq

    11,226.36
    -58.96 (-0.52%)
     
  • Russell 2000

    1,869.19
    +5.67 (+0.30%)
     
  • Crude Oil

    76.28
    -1.66 (-2.13%)
     
  • Gold

    1,754.00
    +8.40 (+0.48%)
     
  • Silver

    21.43
    +0.06 (+0.29%)
     
  • EUR/USD

    1.0405
    -0.0008 (-0.07%)
     
  • 10-Yr Bond

    3.6910
    -0.0150 (-0.40%)
     
  • GBP/USD

    1.2091
    -0.0023 (-0.19%)
     
  • USD/JPY

    139.1000
    +0.5100 (+0.37%)
     
  • BTC-USD

    16,529.70
    -12.12 (-0.07%)
     
  • CMC Crypto 200

    386.97
    +4.32 (+1.13%)
     
  • FTSE 100

    7,486.67
    +20.07 (+0.27%)
     
  • Nikkei 225

    28,283.03
    -100.06 (-0.35%)
     

InMode to Present at the Canaccord 42nd Annual Growth Conference

YOKNEAM, Israel, July 20, 2022 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial Officer, will present at the Canaccord 42nd Annual Growth Conference on Aug. 11, 2022, at the InterContinental Boston hotel.

InMode Logo
InMode Logo

The presentation is scheduled for 3:30 pm Eastern Time on Thursday, Aug. 11 and will be webcast from InMode's Investor Relations website at https://inmodemd.com/investors/. Yair Malca will also hold one-on-one investor meetings on Wednesday, Aug. 10 and Thursday, Aug. 11. To schedule a meeting, please contact your Canaccord representative.

For more information about the event, visit InMode's investor relations site here.

About InMode 

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.

Investor Relations Contact:

Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com   
917-607-8654

Logo: https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg

Cision
Cision

View original content:https://www.prnewswire.com/news-releases/inmode-to-present-at-the-canaccord-42nd-annual-growth-conference-301589932.html

SOURCE InMode Ltd.